Elevate Mushrooms LLC – Trademark Portfolio

Entity Type: 16

Elevate Mushrooms LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ELEVATE. The owner is based in Yarmouth, ME.

44 Pinewood Road

Yarmouth, ME 04096

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ELEVATE
ELEVATE
Registered 2025
ELEVATE
ELEVATE
Registered 2025

Trademark Classifications

Elevate Mushrooms LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (2 filings)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Elevate Mushrooms LLC have?

Elevate Mushrooms LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Elevate Mushrooms LLC file in?

Elevate Mushrooms LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Elevate Mushrooms LLC's most well-known trademarks?

Elevate Mushrooms LLC's registered trademark portfolio includes well-known marks such as ELEVATE. These are among 2 currently registered trademarks in the portfolio.

What is Elevate Mushrooms LLC's trademark registration success rate?

Elevate Mushrooms LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.